Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1321930

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1321930

Global Facial Injectables Market Size, Share, Growth Analysis, By Type(Botulinum Toxin, Collagen), By Application(Wrinkle Reduction, Facelift), By End-User(Hospitals, Ambulatory Surgery Centers) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Facial Injectables Market size was valued at USD 16.1 billion in 2021 and is poised to grow from USD 17.56 billion in 2022 to USD 34.49 billion by 2030, growing at a CAGR of 9.1% in the forecast period (2023-2030).

The global facial injectables market is experiencing significant growth, driven by factors such as the increasing desire for youthful appearance and rising awareness of aesthetic treatments. Facial injectables, including dermal fillers and botulinum toxin, are widely used for wrinkle reduction, lip augmentation, and facial contouring. The market is fueled by advancements in technology, growing disposable income, and expanding aesthetic consciousness. Rising demand for minimally invasive procedures and the growing aging population are expected to further drive the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Facial Injectables and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The global facial injectables market is segmented based on type, application, end-user, and region. Based on type, the facial injectables market is segmented as botulinum toxin, collagen, hyaluronic acid, calcium hydroxyl apatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, others. Based on application, the facial injectables market is segmented as wrinkle reduction, facelift, acne scar therapy, lip augmentation, lipoatrophy treatment, others. Based on end-users, the market is segmented as hospitals and ambulatory surgery centers, dermatology and cosmetic clinics, and others. Based on region, the facial injectables market segmentation spans North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

During the projected period, the demand for facial injectables is expected to increase due to the detrimental effects of environmental pollutants and diverse lifestyle choices on skin health. These injectables consist of collagen fibers, hyaluronic acid fillers, and synthetic fillers..

Restrain

However, the expansion of the market is hindered by stringent regulations, limitations on product usage, and the occurrence of skin issues such as rashes and redness. These obstacles impede the market's growth, particularly in terms of aesthetic applications

Trend

A notable trend in the market is the growing adoption of facial injectables among men. Over the forecast period, it is expected that men will increasingly embrace various fillers, including botulinum toxin and dermal fillers. For example, younger men are choosing tissue fillers as a means to combat aging. This increasing acceptance of facial injectables among the male population is likely to contribute to their higher usage.

Product Code: SQSG35I2006

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Facial Injectables Market by Type
    • Market Overview
    • Botulinum Toxin
    • Collagen
    • Hyaluronic Acid
    • Calcium Hydroxyl Apatite
    • Polylactic Acid
    • Polymethyl-Methacrylate Microspheres (PMMA)
    • Fat Injection
    • Others
  • Global Facial Injectables Market by Application
    • Market Overview
    • Wrinkle Reduction
    • Facelift
    • Acne Scar Therapy
    • Lip Augmentation
    • Lipoatrophy Treatment
    • Others
  • Global Facial Injectables Market by End-User
    • Market Overview
    • Hospitals
    • Ambulatory Surgery Centers
    • Dermatology
    • Cosmetic Clinics
    • Others
  • Global Facial Injectables Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Galderma S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merz Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sinclair Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Suneva Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teoxane Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Anika Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Anteis S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioPolymer GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cynosure, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ipsen Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medytox, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Polymekon s.r.o.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Prollenium Medical Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Q-Med AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Revance Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SciVision Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Syneron Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • VisionMed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!